Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies
Tofacitinib, un inhibidor oral de la quinasa Janus, para el tratamiento de artritis reumatoide en pacientes de Latinoamérica: eficacia y seguridad de estudios fase 3 y de extensión a largo plazo
Sebastião Cezar Radominskia, Mario Humberto Cardielb, Gustavo Citerac, Annelise Goecked, Juan Jose Jallere, Andrea Barranjard Vannucci Lomontef, Pedro Mirandag, Patricia Velezh, Daniel Xibilléi, Kenneth Kwokj, Ricardo Rojok,
Corresponding author
Ricardo.Rojo@pfizer.com

Corresponding author.
, Erika Gabriela Garcíal
a Universidade Federal do Paraná, Curitiba, Brazil
b Centro de Investigación Clínica de Morelia, Morelia, Mexico
c Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
d Instituto de Ciencias Biomédicas, Hospital Clínico de la Universidad de Chile, Santiago, Chile
e University Metropolitana, Barranquilla, Colombia
f Hospital Heliópolis, São Paulo, Brazil
g Centro de Estudios Reumatológicos, Santiago, Chile
h CIREISAS, Bogotá, Colombia
i Hospital General de Cuernavaca, Cuernavaca, Mexico
j Pfizer Inc, New York, NY, USA
k Pfizer Inc, Groton, CT, USA
l Pfizer Inc, Collegeville, PA, USA
Ver más
Read
4756
Times
was read the article
2087
Total PDF
2669
Total HTML
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 53 61 114
2024 October 66 44 110
2024 September 38 20 58
2024 August 70 62 132
2024 July 61 38 99
2024 June 50 38 88
2024 May 64 44 108
2024 April 60 25 85
2024 March 40 41 81
2024 February 33 29 62
2024 January 27 25 52
2023 December 23 32 55
2023 November 26 39 65
2023 October 53 29 82
2023 September 120 41 161
2023 August 30 21 51
2023 July 32 27 59
2023 June 29 31 60
2023 May 39 34 73
2023 April 45 24 69
2023 March 62 33 95
2023 February 46 33 79
2023 January 32 25 57
2022 December 62 40 102
2022 November 65 38 103
2022 October 36 53 89
2022 September 42 41 83
2022 August 32 46 78
2022 July 29 38 67
2022 June 44 34 78
2022 May 39 34 73
2022 April 44 26 70
2022 March 41 46 87
2022 February 34 44 78
2022 January 52 49 101
2021 December 41 37 78
2021 November 40 49 89
2021 October 58 47 105
2021 September 33 45 78
2021 August 22 39 61
2021 July 14 25 39
2021 June 19 23 42
2021 May 38 35 73
2021 April 100 58 158
2021 March 76 36 112
2021 February 30 21 51
2021 January 27 14 41
2020 December 42 25 67
2020 November 24 16 40
2020 October 18 11 29
2020 September 36 26 62
2020 August 64 27 91
2020 July 22 20 42
2020 June 38 14 52
2020 May 35 11 46
2020 April 16 18 34
2020 March 10 4 14
2020 February 2 0 2
2018 December 2 0 2
2018 May 2 3 5
2018 April 31 7 38
2018 March 38 10 48
2018 February 17 8 25
2018 January 13 12 25
2017 December 21 20 41
2017 November 18 15 33
2017 October 25 28 53
2017 September 7 16 23
2017 August 35 37 72
2017 July 36 45 81
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?